SCIEX And Children's Medical Research Institute Join Forces To Advance The Promise Of Precision Medicine

FRAMINGHAM, Mass. & SYDNEY--(BUSINESS WIRE)--SCIEX, a global leader in life science analytical technologies, today announced their alliance with Children’s Medical Research Institute (CMRI) to equip The Australian Cancer Research Foundation International Centre for the Proteome of Cancer (ProCanTM) facility with the solutions and tools required for the advancement of their large-scale proteomic profiling studies. These studies will profile thousands of tumour samples per year, enable discoveries around the causes of cancer, provide guidance of cancer treatment options, and work to produce standard operating procedures for other facilities around the world. ProCan will be established with $10 million in seed money from The Australian Cancer Research Foundation to purchase the SCIEX equipment.